Comparison of immediate results and follow-up of patients with single-vessel and multivessel coronary artery disease younger than 50 years of age undergoing coronary stent implantation

Autor: Maria Fernanda Zuliani Mauro, Adnan Ali Salman, João Batista de Oliveira Neto, José Armando Mangione, Isaac Moscoso, Alexandre L. Anello, Ricardo José Tofano, Salvador André Bavaresco Cristóvão
Jazyk: angličtina
Rok vydání: 2003
Předmět:
Zdroj: Arquivos Brasileiros de Cardiologia, Vol 81, Iss 5, Pp 500-505 (2003)
Arquivos Brasileiros de Cardiologia, Volume: 81, Issue: 5, Pages: 500-505, Published: NOV 2003
Arquivos Brasileiros de Cardiologia v.81 n.5 2003
Arquivos Brasileiros de Cardiologia
Sociedade Brasileira de Cardiologia (SBC)
instacron:SBC
ISSN: 1678-4170
Popis: OBJECTIVE: To assess the in-hospital results and clinical follow-up of young patients (< 50 years) with multivessel coronary artery disease undergoing stent implantation in native coronary arteries and to compare their results with those of patients with single-vessel coronary artery disease. METHODS: We retrospectively studied 462 patients undergoing coronary stent implantation. Patients were divided into 2 groups: group I (G-I) - 388 (84%) patients with single-vessel coronary artery disease; and group II (G-II) - 74 (16%) patients with multivessel coronary artery disease. RESULTS: The mean age of the patients was 45±4.9 years, and the clinical findings at presentation and demographic data were similar in both groups. The rate of clinical success was 95% in G-I and 95.8% in G-II (P=0.96), with no difference in regard to in-hospital evolution between the groups. Death, acute myocardial infarction, and the need for myocardial revascularization during clinical follow-up occurred in 10.1% and 11.2% (P=0.92) in G-I and G-II, respectively. By the end of 24 months, the actuarial analysis showed an event-free survival of 84.6 % in G-I and 81.1% in G-II (P=0.57). CONCLUSION: Percutaneous treatment with coronary stent implantation in young patients with multivessel disease may be safe with a high rate of clinical success, a low incidence of in-hospital complications, and a favorable evolution in clinical follow-up.
Databáze: OpenAIRE